good morning fellow SH's. quarterly is out and certainly looks promising. you may recall me making mention of assessing a company through its balance sheet and P&L. out of the majority of the small cap bio stocks, I still maintain that SUD is the most promising.
cash flow positive and likelihood of a cash flow positive next quarter. throw in a couple more deals and one would even start to believe that this may even be a real company maker.
as always, DYOR and make your own judgement. GLTAH
SUD Price at posting:
0.5¢ Sentiment: Hold Disclosure: Held